Opaleye Management’s Biohaven BHVN Stock Holding History

Opaleye Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,000	Closed	-$8.56M	–	54
2023 Q4	$8.56M	Sell	200,000 -239,000	-54%	-$7.43M	2.28%	13
2023 Q3	$11.4M	Sell	439,000 -101,000	-19%	-$2.1M	3.71%	8
2023 Q2	$12.9M	Hold	540,000	–	–	3.09%	7
2023 Q1	$7.38M	Hold	540,000	–	–	2.21%	11
2022 Q4	$7.5M	Buy	+540,000	New	+$7.63M	2.61%	9

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Opaleye Management's BHVN Position: Q1 2024 in Review

Opaleye Management sold out of Biohaven (BHVN) in Q1 2024, closing a stake of 200,000 shares — an estimated $8.56M sold.

Opaleye Management first reported a position in BHVN in Q4 2022 and held it in 5 quarters. The position peaked at $12.9M in Q2 2023. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

Opaleye Management reported no remaining Biohaven position as of Q1 2024 after selling out during the quarter.
Opaleye Management sold 200,000 Biohaven shares in Q1 2024, an estimated $8.56M.
Opaleye Management first reported a position in Biohaven in Q4 2022 and held it in 5 quarters.
Opaleye Management's Biohaven position peaked at $12.9M in Q2 2023.
243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on Opaleye Management's 13F filing for Q1 2024, filed 15 May 2024.